Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

A new study published today in JAMA Network Open shows that respiratory syncytial virus (RSV) was associated with a ...

The NHS is urging eligible patients to protect themselves this winter by getting vaccinated against respiratory syncytial ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically ...

As of last year, RSV vaccination with Abrysvo has been recommended for pregnant women in the United States from 32 to 36 ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

Wisconsin Department of Health Services (DHS) data show only 17% of Wisconsinites have received a flu shot this season, and ...

As cold and flu season ramps up, the most vulnerable among us need extra protection. Infants are among the most susceptible ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...